A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Clinical trial NCT00988052 · TERMINATED

Trial details

NCT number: NCT00988052
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2009-11-10
Primary completion: 2017-07-01
Enrollment: 839

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.